Search filters

List of works by Eugènia Negredo

48-week outcomes following switch from AZT/3TC to FTC/TDF (TVD) vs. continuing on AZT/3TC: 48-week interim analysis of the RECOMB trial

scholarly article by E Ribera et al published 2008 in Journal of the International AIDS Society

99mTc-HMPAO SPET: a method to study visual loss in cryptococcal meningitis

scientific article published on 01 November 2000

A Multi-state Model for the Progression to Osteopenia and Osteoporosis Among HIV-Infected Patients

article

A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction

scientific article published on 13 July 2020

A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen.

scientific article published in August 2013

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV

scientific article published on 17 September 2020

A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients

scientific article published in March 2009

A week 48 randomized phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve HIV-1 patients

scientific article published on 19 April 2018

Adherence and health beliefs in a psychoeducative intervention in naïve HIV-1-infected men: the PROADH study.

scientific article published on 11 November 2012

Aging in HIV-Infected Subjects: A New Scenario and a New View

scientific article published on 21 December 2017

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial

scientific article

Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study

scientific article published in December 2004

Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults

article

Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile

scientific article (publication date: 2012)

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes

scientific article published on 16 July 2016

Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

scientific article published in July 2001

Assessing Self-Reported Adherence to HIV Therapy by Questionnaire: The SERAD (Self-Reported Adherence) Study

article

Assessing main death pathways in T lymphocytes from HIV infected individuals.

scientific article

Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART.

scientific article

Association between lipid genetic and immunological status in chronically HIV-infected patients

scientific article published on 2 November 2014

Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients

scientific article published on 8 December 2014

Atherogenic properties of lipoproteins in HIV patients starting atazanavir/ritonavir or darunavir/ritonavir: a substudy of the ATADAR randomized study

scientific article published on 23 December 2014

Autoantibodies against thyroid hormones can lead to an erroneous diagnosis and potentially harmful treatment

scientific article published on 01 January 1998

Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.

scientific article published on January 1999

Benefits and concerns of simplification strategies in HIV-infected patients

scientific article published on 27 June 2006

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART

scientific article published on 01 April 2010

COVIDApp: A Health Application as an Innovative Strategy for the Management and Follow-Up of the COVID-19 Pandemic in Long-Term Care Facilities in Catalonia

scientific article published on 06 July 2020

Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables

scientific article

Clinical and Emotional Factors Related to Erectile Dysfunction in HIV-Infected Men.

scientific article published on 19 September 2016

Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 years

scientific article published on 6 May 2015

Compromised immunologic recovery in patients receiving tipranavir/ritonavir coadministered with tenofovir and didanosine in Randomized Evaluation of Strategic Intervention in multidrug-resiStant patients with tipranavir (RESIST) studies

scientific article published on 01 August 2007

Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies

scientific article published on 15 August 2005

Consensus document on the management of renal disease in HIV-infected patients.

scientific article

Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus

scientific article published on 28 August 2014

Consensus statement: recommendations for the management of metabolic bone disease in human immunodeficiency virus patients

scientific article

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons

scientific article published on 26 March 2013

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

scientific article

Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial

scientific article published on 10 November 2014

Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients.

scientific article

Disorders of body fat distribution in HIV-1-infected patients

scientific article published on July 2009

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

scientific article published on 01 July 2018

Dynamics of the decay of HIV RNA and distribution of bictegravir in the genital tract and rectum in antiretroviral-naïve HIV-1-infected adults treated with bictegravir/emtricitabine/tenofovir alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS

scientific article published on 18 September 2020

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

scientific article published on 14 May 2013

Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients

scientific article published in March 2004

Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients.

scientific article

Effect of nevirapine on the steady-state trough concentrations of atazanavir in HIV-infected patients receiving atazanavir/ritonavir

scientific article published in February 2010

Effect of pneumococcal vaccine on plasma HIV-1 RNA of stable patients undergoing effective highly active antiretroviral therapy

scientific article published on 01 April 2001

Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis

scientific article (publication date: 2011)

Efficacy and safety of ritonavir dose reduction based on the tipranavir inhibitory quotient in HIV-infected patients on salvage antiretroviral therapy with tipranavir/ritonavir

scientific article published on 23 September 2010

Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically

scientific article published on 5 October 2017

Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1

article

Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.

scientific article published on 21 September 2017

Emotional impact of premature aging symptoms in long-term treated HIV-infected subjects.

scientific article

Evaluation of protease inhibitors containing tubes for MS-based plasma peptide profiling studies.

scientific article

Evaluation of the anti-HIV activity of statins

scientific article published in October 2005

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.

scientific article published on 03 August 2014

Executive summary of the consensus document on osteoporosis in HIV-infected individuals.

scientific article published on 31 May 2017

Executive summary of the consensus document on the management of renal disease in HIV-infected patients.

scientific article

Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

scientific article published on 7 October 2014

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins

Factors associated with the number of drugs in darunavir/cobicistat regimens

scientific article published in January 2020

Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy

scientific article (publication date: April 2009)

Frequency of bone abnormalities and associated factors in a Spanish cohort of HIV-infected patients

article

Genetic and functional mitochondrial assessment of HIV-infected patients developing HAART-related hyperlactatemia

scientific article published in December 2009

Gut Microbiota Linked to Sexual Preference and HIV Infection.

scientific article

HIV and syphilis: when to perform a lumbar puncture

scientific article published in March 2007

HIV protease inhibitors and dyslipidemia

scientific article

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain

scientific article published in November 2009

HIV-associated polymyositis with life-threatening myocardial and esophageal involvement

scientific article published on 01 May 1999

Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts.

scientific article published in April 2008

Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients

scientific article

Herb-drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV-infected patients.

scientific article published on 8 November 2010

Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patients

scientific article

High Prevalence of Sarcopenia in HIV-Infected Individuals

article

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

scientific article published on November 2010

High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.

scientific article published on 19 September 2014

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

scientific article published on 6 August 2012

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

scientific article published in 2018

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response

scientific article published on 01 October 1999

Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV

scientific article published on June 2016

Immunodiscordant responses to HAART--mechanisms and consequences

scientific article

Immunological function restoration with lopinavir/ritonavir versus efavirenz containing regimens in HIV-infected patients: a randomized clinical trial

scientific article published on 10 February 2014

Impact of HIV infection on aging and immune status

scientific article published on 09 November 2020

Impact of nevirapine on lipid metabolism

scientific article published on September 2003

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study.

scientific article published on August 2016

Impact of switching from lopinavir/ritonavir to atazanavir/ritonavir on body fat redistribution in virologically suppressed HIV-infected adults

scientific article published on 15 January 2011

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.

scientific article published on 9 January 2013

Impotence as a cardinal sign in the thromboangiitis obliterans diagnosis

scientific article published on 01 November 1995

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)

scientific article published on 13 August 2014

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

scientific article published in September 2009

In Vivo, Non-Invasive Characterization of Human Bone by Hybrid Broadband (600-1200 nm) Diffuse Optical and Correlation Spectroscopies

scientific article

Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients

scientific article published in January 2006

Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor associated hypercholesterolaemia.

scientific article published on 19 April 2018

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery

scientific article published on 17 July 2015

Influence of Prior Structured Treatment Interruptions on the Length of Time without Antiretroviral Treatment in Chronically HIV-Infected Subjects

article

Influence of coinfection with hepatitis viruses on human immunodeficiency plasma viral load.

scientific article published in October 1999

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

scientific article published in May 2010

Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy

scientific article published on 25 November 2019

Long-term changes in bone mineral density after switching to a protease inhibitor monotherapy in HIV-infected subject

scientific article published on 29 April 2015

Long-term effectiveness and safety outcomes in HIV-1-infected patients after a median time of 6 years on nevirapine

scientific article published in September 2009

Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence

scientific article published in April 2005

Long-term satisfaction and benefits on quality of life in HIV-infected people after reparatory treatment with Aquamid® for facial Lipoatrophy

article

Longitudinal study on mitochondrial effects of didanosine-tenofovir combination

scientific article published in January 2006

Lopinavir/ritonavir monotherapy as a simplification strategy in routine clinical practice

scientific article published on 07 June 2007

Lopinavir/ritonavir pharmacokinetics in HIV and hepatitis C virus co-infected patients without liver function impairment: influence of liver fibrosis.

scientific article published in January 2007

Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study).

scientific article published in January 2005

Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders

scientific article published on 01 June 2009

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

article

Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovir

scientific article published in January 2011

Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients

scientific article published on 05 March 2020

Management of bone mineral density in HIV-infected patients

scientific article

Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients

scientific article

Memory B cell dysregulation in HIV-1-infected individuals.

scientific article published on 2 November 2017

Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite persistent impairment of mitochondrial DNA content

scientific article published in July 2010

Mitochondrial effects of 3 years of CD4-guided HIV treatment interruption

article

Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice.

scientific article published in October 2007

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

article

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients

scientific article published in October 2008

Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review

scientific article published on April 2009

Once- or twice-daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach

scientific article published on 30 June 2008

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

scientific article published in March 2005

Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens.

scientific article published in January 2008

Peak bone mass in young HIV-infected patients compared with healthy controls

scientific article

Pharmacologic approaches to the prevention and management of low bone mineral density in HIV-infected patients

scientific article published on 17 February 2016

Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir

scientific article published on 09 March 2009

Polymorphisms in LPL, CETP, and HL Protect HIV-Infected Patients from Atherogenic Dyslipidemia in an Allele-Dose-Dependent Manner

article

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner

scientific article

Potential prescribing issues among older HIV-infected persons in a Mediterranean cohort: Does the current prevalence give cause for concern?

scientific article published on 27 August 2020

Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery

scientific article published on 15 September 2017

Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohorts

scientific article

Prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a Mediterranean cohort of HIV-infected patients

scientific article

Prevalence of parvovirus B19 infection among patients with human immunodeficiency virus infection in Barcelona, Spain.

scientific article published in March 1998

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals.

scientific article published on September 2017

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

scientific article published on 18 December 2016

Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy

scientific article

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

scientific article published on 01 January 2014

Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens

scientific article

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

scientific article published on November 2012

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

scientific article

Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC.

scientific article published on 2 November 2014

Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances.

scientific article published in December 2006

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

scientific article published on 01 July 2019

Reversal of HIV-1-associated osteoporosis with once-weekly alendronate

scientific article published in February 2005

Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine

scientific article

Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.

scientific article

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection

scientific article

Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach

scientific article published in June 2004

Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients

scientific article published in April 2009

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis

scientific article published on 11 March 2009

Saquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy in long-term virologically suppressed HIV-infected patients

scientific article published on September 2010

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome

scientific article published on 20 March 2013

Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia

scientific article published on 3 July 2017

Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).

scientific article published on 24 November 2009

Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.

scientific article published in January 2005

Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.

scientific article published in January 2008

Specificity enhancement with LC-positive ESI-MS/MS for the measurement of nucleotides: application to the quantitative determination of carbovir triphosphate, lamivudine triphosphate and tenofovir diphosphate in human peripheral blood mononuclear ce

scientific article published in February 2008

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

scientific article

Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.

scientific article

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.

scientific article published on 20 December 2016

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.

scientific article published on 13 March 2015

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

scientific article published on 11 December 2014

Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial

scientific article published on 25 January 2013

Switching to Raltegravir in Virologically Suppressed in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study

article

TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses

scientific article published on 11 November 2020

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.

scientific article published on 15 May 2008

Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients

scientific article published on 5 May 2015

The changing face of HIV/AIDS in treated patients

scientific article published on July 2009

The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy

scientific article published in February 2006

The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial

scientific article published on 13 April 2015

Therapeutic management of bone demineralization in the HIV-infected population

scientific article published on 01 March 2007

Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan

scientific article

Time-resolved diffused optical characterization of key tissue constituents of human bony prominence locations

Transient therapy with quadruple NRTI provides immune stability in patients with multidrug resistant HIV-1 and no options for suppressive regimens

article

Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.

scientific article published in November 2008

Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in heavily pretreated HIV-infected patients.

scientific article published in January 2010

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

scientific article published in February 2004

Usefulness of the I/D angiotensin-converting enzyme genotype for detecting the risk of left ventricular hypertrophy in pharmacologically treated hypertensive men

scientific article published on 01 May 2000

Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort

scientific article published on 29 September 2010

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals

scientific article published on 22 March 2017

Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide

scientific article published on 01 September 2006

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

scientific article published on 2 January 2002

Visual loss due to cryptococcal meningitis in AIDS patients

scientific article published on 01 March 1999

Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (

scientific article published on 4 October 2017

[A 50-year-old male with AIDS and retroperitoneal mass]

scientific article published on 01 June 2007

[Cardiovascular risk and human immunodeficiency virus infection: A new clinical challenge]

scientific article published on 01 July 2010

[Contribution of human papillomavirus second-generation hybrid capture test for the diagnosis of cervical pathology in HIV-infected outpatients].

scientific article

Paulina is supported by:

About Paulina

Help